Home

fallimento Pasqua gasping c myc inhibitors clinical trials sol Ammissione salato

IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven  Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML

Therapeutic targeting of “undruggable” MYC - eBioMedicine
Therapeutic targeting of “undruggable” MYC - eBioMedicine

Targeting c-Myc signaling in AML. a c-Myc (MYC) transcription is... |  Download Scientific Diagram
Targeting c-Myc signaling in AML. a c-Myc (MYC) transcription is... | Download Scientific Diagram

MYC inhibitors in multiple myeloma
MYC inhibitors in multiple myeloma

Taking the Myc out of cancer: toward therapeutic strategies to directly  inhibit c-Myc | Molecular Cancer | Full Text
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text

IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven  Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML

Small-molecule inhibitors of c-Myc transcriptional factor suppress  proliferation and induce apoptosis of promyelocytic leukemia cell via cell  cycle arrest - Molecular BioSystems (RSC Publishing)
Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest - Molecular BioSystems (RSC Publishing)

Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability |  Cell and Developmental Biology
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based |  DDDT
Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based | DDDT

Therapeutic targeting of “undruggable” MYC - eBioMedicine
Therapeutic targeting of “undruggable” MYC - eBioMedicine

Mission Possible: Advances in MYC Therapeutic Targeting in Cancer |  SpringerLink
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer | SpringerLink

Alternative approaches to target Myc for cancer treatment | Signal  Transduction and Targeted Therapy
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy

Reproducibility in Cancer Biology: Small molecules remain on target for c- Myc | eLife
Reproducibility in Cancer Biology: Small molecules remain on target for c- Myc | eLife

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

A role for c-Myc as a key signaling node. The expression of... | Download  Scientific Diagram
A role for c-Myc as a key signaling node. The expression of... | Download Scientific Diagram

Taking the Myc out of cancer: toward therapeutic strategies to directly  inhibit c-Myc | Molecular Cancer | Full Text
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text

IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven  Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML

Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability |  Cell and Developmental Biology
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

Therapeutic targeting of “undruggable” MYC - eBioMedicine
Therapeutic targeting of “undruggable” MYC - eBioMedicine

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization  and induces apoptosis in cancer cells - Journal of Biological Chemistry
A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells - Journal of Biological Chemistry

Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability |  Cell and Developmental Biology
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology

Taking the Myc out of cancer: toward therapeutic strategies to directly  inhibit c-Myc | Molecular Cancer | Full Text
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text

Targeting MYC: From understanding its biology to drug discovery -  ScienceDirect
Targeting MYC: From understanding its biology to drug discovery - ScienceDirect